
Opinion|Videos|May 5, 2025
Diagnosis of cGVHD: Challenges & Considerations
Panelists discuss how difficult-to-diagnose cases of chronic graft-vs-host disease (cGVHD) often include pulmonary involvement, gynecological manifestations, and neurological symptoms.
Advertisement
Episodes in this series

Difficult-to-Diagnose Manifestations
The panelists discussed challenging presentations:
- Pulmonary involvement is often insidious, requiring careful monitoring with serial PFTs
- Genital/gynecologic involvement is often underdiagnosed but impacts quality of life significantly
- Neuropathies are difficult to attribute to cGVHD due to multiple potential causes
- Peripheral edema can make assessment of skin thickening/sclerosis challenging
- Serositis (inflammation of tissue lining around heart, lungs, abdomen) is difficult to diagnose and manage
- Immune cytopenias within the cGVHD syndrome can be challenging
Early detection strategies include:
- Serial PFTs (pre-transplant, day 80-90, 6 months, 12 months, 18 months, 2 years)
- Early ophthalmology and dental evaluations
- Patient education about reporting symptoms early
- Regular scheduled follow-ups via telehealth or in-person
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
De-Escalated Neoadjuvant HER2-Targeted Therapy Shows Durable 5-Year Survival
2
Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma
3
Safusidenib Shows Durable Responses in IDH1-Mutant Glioma at 3-Year Follow-Up
4
Thoracic Radiotherapy Added to Atezolizumab Raised Toxicity in SCLC
5


























